{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T01:38:25Z","timestamp":1649813905229},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","surgpath.theclinics.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.path.2015.11.001","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T01:34:05Z","timestamp":1456882445000},"page":"29-40","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Expanding Spectrum of Follicular Lymphoma"],"prefix":"10.1016","volume":"9","author":[{"given":"Yuri","family":"Fedoriw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.path.2015.11.001_bib1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A\u00a0clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2015.11.001_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hon.2900010209","article-title":"Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method","volume":"1","author":"Mann","year":"1983","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.path.2015.11.001_bib3","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"3","key":"10.1016\/j.path.2015.11.001_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1182\/blood.V101.3.1149","article-title":"Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive","volume":"101","author":"Bosga-Bouwer","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2015.11.001_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/sj.leu.2403738","article-title":"Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances","volume":"19","author":"Guo","year":"2005","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.path.2015.11.001_bib6","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","article-title":"Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3","volume":"99","author":"Ott","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.path.2015.11.001_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3324\/haematol.12754","article-title":"Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas","volume":"93","author":"Piccaluga","year":"2008","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.path.2015.11.001_bib8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.path.2015.11.001_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1309\/AJCP5FP3NAXAXRJE","article-title":"The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities","volume":"131","author":"Gratzinger","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.path.2015.11.001_bib10","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/PAS.0b013e3181e9343d","article-title":"Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components","volume":"34","author":"Younes","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2015.11.001_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.2011.08942.x","article-title":"Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times","volume":"156","author":"Wahlin","year":"2012","journal-title":"Br J Haematol"},{"issue":"26","key":"10.1016\/j.path.2015.11.001_bib12","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource","volume":"31","author":"Link","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"27","key":"10.1016\/j.path.2015.11.001_bib13","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new\u00a0prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project","volume":"27","author":"Federico","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2015.11.001_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3324\/haematol.10384","article-title":"The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma","volume":"92","author":"Koster","year":"2007","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.path.2015.11.001_bib15","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1158\/1078-0432.CCR-13-2367","article-title":"Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma","volume":"20","author":"Smeltzer","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2015.11.001_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(13)70551-5","article-title":"Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial","volume":"15","author":"Westin","year":"2014","journal-title":"Lancet Oncol"},{"issue":"7360","key":"10.1016\/j.path.2015.11.001_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.path.2015.11.001_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.path.2015.11.001_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cell.2011.09.035","article-title":"The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma","volume":"147","author":"Oricchio","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.path.2015.11.001_bib20","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/1097-0142(197912)44:6<2218::AID-CNCR2820440634>3.0.CO;2-D","article-title":"Follicular (nodular) lymphoma in childhood: a rare clinical-pathological entity. Report of eight cases from four cancer centers","volume":"44","author":"Frizzera","year":"1979","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.path.2015.11.001_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2015.11.001_bib22","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.V99.6.1959","article-title":"Clinicopathologic analysis of follicular lymphoma occurring in children","volume":"99","author":"Lorsbach","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2015.11.001_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(01)00436-8","article-title":"Interphase detection of immunoglobulin heavy chain gene translocations with specific oncogene loci in 173 patients with B-cell lymphoma","volume":"129","author":"Tamura","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"issue":"10","key":"10.1016\/j.path.2015.11.001_bib24","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.humpath.2014.06.019","article-title":"Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis","volume":"45","author":"Xerri","year":"2014","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.path.2015.11.001_bib25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Martin-Guerrero","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.path.2015.11.001_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1309\/4EJ8T3R2ERKQ61WH","article-title":"Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations","volume":"121","author":"Kussick","year":"2004","journal-title":"Am\u00a0J Clin Pathol"},{"issue":"1","key":"10.1016\/j.path.2015.11.001_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MPH.0b013e31820e4636","article-title":"Primary follicular lymphoma of the testis in children and adolescents","volume":"34","author":"Lones","year":"2012","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.path.2015.11.001_bib28","first-page":"1093","article-title":"Localised non-Hodgkin lymphoma of the testis: the Sheffield Lymphoma Group experience","volume":"26","author":"Darby","year":"2005","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.path.2015.11.001_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00043426-200402000-00007","article-title":"Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy","volume":"26","author":"Heller","year":"2004","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.path.2015.11.001_bib30","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A\u00a0distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.path.2015.11.001_bib31","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2015.11.001_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.12596","article-title":"Recent advances in intestinal lymphomas","volume":"66","author":"Foukas","year":"2015","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.path.2015.11.001_bib33","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1349-7006.2011.01980.x","article-title":"Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan","volume":"102","author":"Takata","year":"2011","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.path.2015.11.001_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/modpathol.2012.127","article-title":"Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics","volume":"26","author":"Takata","year":"2013","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.path.2015.11.001_bib35","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/modpathol.2009.51","article-title":"Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations","volume":"22","author":"Takata","year":"2009","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.path.2015.11.001_bib36","doi-asserted-by":"crossref","first-page":"329.e1","DOI":"10.1016\/j.jaad.2013.06.012","article-title":"Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification","volume":"69","author":"Suarez","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.path.2015.11.001_bib37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCP4SUBR4NPSPTN","article-title":"Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions","volume":"143","author":"Pham-Ledard","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.path.2015.11.001_bib38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00000478-200206000-00006","article-title":"Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity","volume":"26","author":"Goodlad","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2015.11.001_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.23863","article-title":"Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management","volume":"90","author":"Wilcox","year":"2015","journal-title":"Am J Hematol"},{"issue":"16","key":"10.1016\/j.path.2015.11.001_bib40","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.path.2015.11.001_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1309\/AJCPNLC9NC9WTQYY","article-title":"Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop","volume":"139","author":"Swerdlow","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.path.2015.11.001_bib42","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: description and analysis by laser capture microdissection","volume":"99","author":"Cong","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2015.11.001_bib43","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","author":"Jegalian","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.path.2015.11.001_bib44","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3324\/haematol.2013.085506","article-title":"Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies","volume":"98","author":"Pillai","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.path.2015.11.001_bib45","article-title":"Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden","volume":"5","author":"Fend","year":"2012","journal-title":"J\u00a0Hematop"},{"issue":"5","key":"10.1016\/j.path.2015.11.001_bib46","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3324\/haematol.2013.085548","article-title":"Nature and importance of follicular lymphoma precursors","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.path.2015.11.001_bib47","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/01.pas.0000173233.29741.38","article-title":"Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage","volume":"29","author":"Adam","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2015.11.001_bib48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918115001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918115001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T10:35:21Z","timestamp":1600252521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918115001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1875918115001348"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2015.11.001","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Expanding Spectrum of Follicular Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2015.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}